Home
About
Company Background
Senior Management
Board of Directors
Scientific Advisors
Collaborations
Expanded Access
Contact Us
Science
Overview
Prurisol
Kevetrin
Brilacidin
Pipeline
Therapeutic Areas
Stages of Development
FDA Designations
Investors
Stock Information
Financials & Filings
Corporate Governance
Investor FAQ
Newsroom
Welcome
Press Releases
Events and Presentations
Blog
Email Alerts
Stock Symbol: IPIX
Clinical Trials
Latest News
EMAIL ALERTS
Stock Symbol: IPIX
Clinical Trials
Latest News
EMAIL ALERTS
Home
About
Company Background
Senior Management
Board of Directors
Scientific Advisors
Collaborations
Expanded Access
Contact Us
Science
Overview
Prurisol
Kevetrin
Brilacidin
Pipeline
Therapeutic Areas
Stages of Development
FDA Designations
Investors
Stock Information
Financials & Filings
Corporate Governance
Investor FAQ
Newsroom
Welcome
Press Releases
Events and Presentations
Blog
Email Alerts
Newsroom
Welcome
Press Releases
Events and Presentations
Blog
Email Alerts
Back to all Events
Pre-Clinical Studies: “Efficacy of Kevetrin or Paclitaxel in A549 Drug Resistant Tumor” (Lung Cancer)
July, 2012
Summary